NO117866B - - Google Patents

Download PDF

Info

Publication number
NO117866B
NO117866B NO163322A NO16332266A NO117866B NO 117866 B NO117866 B NO 117866B NO 163322 A NO163322 A NO 163322A NO 16332266 A NO16332266 A NO 16332266A NO 117866 B NO117866 B NO 117866B
Authority
NO
Norway
Prior art keywords
acid
react
ester
allowed
monocarboxylic acid
Prior art date
Application number
NO163322A
Other languages
Norwegian (no)
Inventor
R Bathelt
C Panis
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of NO117866B publication Critical patent/NO117866B/no

Links

Classifications

    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01JELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J29/00Details of cathode-ray tubes or of electron-beam tubes of the types covered by group H01J31/00
    • H01J29/86Vessels; Containers; Vacuum locks
    • H01J29/867Means associated with the outside of the vessel for shielding, e.g. magnetic shields
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01JELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J29/00Details of cathode-ray tubes or of electron-beam tubes of the types covered by group H01J31/00
    • H01J29/86Vessels; Containers; Vacuum locks
    • H01J29/87Arrangements for preventing or limiting effects of implosion of vessels or containers

Landscapes

  • Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
  • Image-Pickup Tubes, Image-Amplification Tubes, And Storage Tubes (AREA)
  • Hydrogenated Pyridines (AREA)

Description

Fremgangsmåte til fremstilling av anestetisk virkende amider av N-alkylpiperidin-monokarbonsyre og N-alkylpyrrolidin-«-monokarbonsyre. Process for the production of anesthetically effective amides of N-alkylpiperidine-monocarboxylic acid and N-alkylpyrrolidine-«-monocarboxylic acid.

Foreliggende oppfinnelse angår en The present invention relates to a

fremgangsmåte til fremstilling av amider method for the production of amides

av N-alkylpiperidin-monokarbonsyre og of N-alkylpiperidine monocarboxylic acid and

av N-alkylpyrrolidin-a-monokarbonsyre, of N-alkylpyrrolidine-α-monocarboxylic acid,

hvilke amider har de generelle formler: which amides have the general formulas:

I disse formler betegner R, en alkylgruppe med mindre enn 10 kullstoffato-mer, R2 en lavere alkylgruppe eller et kloratom, R,, et hydrogenatom, en hydroksyl-gruppe, en lavere alkylgruppe eller en alkoksygruppe og R4 et hydrogenatom, et In these formulas R denotes an alkyl group with less than 10 carbon atoms, R 2 denotes a lower alkyl group or a chlorine atom, R 1 denotes a hydrogen atom, a hydroxyl group, a lower alkyl group or an alkoxy group and R 4 a hydrogen atom, a

kloratom, en lavere alkylgruppe eller en chlorine atom, a lower alkyl group or a

alkoksygruppe. Alternativt kan R2, R3 og alkoxy group. Alternatively, R2, R3 and

R4 alle være hydrogen i en og samme forbindelse. Karbonsyreamidgruppen kan R4 can all be hydrogen in one and the same compound. The carboxylic acid amide group can

være tilknyttet piperidinringen i alfa-, be attached to the piperidine ring in alpha-,

beta- eller gammastillingen. the beta or gamma position.

Disse amider har vist seg å være meget These amides have been shown to be very

gode lokalanestetika med giftighet som er meget liten i forhold til forbindelsenes aktivitet. good local anesthetics with toxicity that is very small compared to the activity of the compounds.

De karakteristiske hovedtrekk ved fremgangsmåten ifølge oppfinnelsen er at man lar et anilinmagnesiumhalogenid med den generelle formel: The main characteristic features of the method according to the invention are that one leaves an aniline magnesium halide with the general formula:

i hvilken X betegner halogen og R2, R3 og R4 har de ovenfor angitte betydninger, reagere med en pyridin-monokarbonsyreester eller med en piperidin-monokarbonsyreester eller en pyrrol-a-monokarbonsyreester eller en pyrrolidin-a-monokarbonsyre-ester, hvilke estere kan være hydrerte eller ikke hydrerte, alkylerte eller ikke alkylerte ved nitrogenatomet i den heterocykliske ring, hvorpå man hydro-lyser er det erholdte reaksjonsprodukt med en syre og i tilfelle hvor utgangsmaterialet er en pyridin-monokarbonsyreester eller en pyrrbl-a-monokarbonsyreester underkaster den heterocykliske ring en hydrering med derpå følgende alkylering av nitrogenet i den heterocykliske ring, f. eks. med et dialkylsulfat eller alkylhalogenid. Hydreringen kan utføres med metallisk natrium eller fortrinsvis med vanlige hyd-reringskatalysatorer. in which X denotes halogen and R 2 , R 3 and R 4 have the meanings given above, react with a pyridine monocarboxylic acid ester or with a piperidine monocarboxylic acid ester or a pyrrole α-monocarboxylic acid ester or a pyrrolidine α-monocarboxylic acid ester, which esters can be hydrogenated or not hydrogenated, alkylated or not alkylated at the nitrogen atom of the heterocyclic ring, after which the reaction product obtained is hydrolysed with an acid and in the case where the starting material is a pyridine monocarboxylic acid ester or a pyrrbl-α-monocarboxylic acid ester the heterocyclic ring is subjected to a hydrogenation with subsequent alkylation of the nitrogen in the heterocyclic ring, e.g. with a dialkyl sulfate or alkyl halide. The hydrogenation can be carried out with metallic sodium or preferably with ordinary hydrogenation catalysts.

I det følgende beskrives som eksemp- In the following, it is described as an example

ler noen utførelsesformer for oppfinnelsen. shows some embodiments of the invention.

Eksempel 1: Example 1:

Etylmagnesiumbromid fremstilles på Ethylmagnesium bromide is produced on

vanlig måte ved å la 185 vektsdeler etyl- usual way by allowing 185 parts by weight of ethyl

bromid i 100 deler vannfri eter reagere med 37 deler magnesium-dreiespon. Under kraftig omrøring tilsettes det derpå 121 bromide in 100 parts of anhydrous ether react with 37 parts of magnesium turnings. With vigorous stirring, 121 is then added

deler 2,6-dimetylanilin med en hastighet som er avhengig av gassutviklingens vold- splits 2,6-dimethylaniline at a rate that depends on the violence of gas evolution

somhet. Når gassutviklingen er opphørt, sameness. When gas development has ceased,

tilsettes suspensjonen av 2,6-dimetylanilin-magnesiumbromid 85 deler N-metyl-pipekolinsyre-etylester. Blandingen opp- is added to the suspension of 2,6-dimethylaniline-magnesium bromide 85 parts of N-methyl-pipecolic acid ethyl ester. The mixture up-

varmes under tilbakeløpskjøling y2 time under stadig omrøring, hvorpå den ned- is heated under reflux cooling for 2 hours with constant stirring, after which the

kjøles. Fortynnet saltsyre tilsettes forsik- cooled. Diluted hydrochloric acid is added to ensure

tig for å oppløse og hydrolysere de dan- to dissolve and hydrolyze the resulting

nende maghesiumforbindelser. pH-verdien innstilles på 5.5, den vandige fase fraskil- nende magnesium compounds. The pH value is set to 5.5, the aqueous phase separates

les og ekstraheres med ytterligere meng- read and extracted with additional amounts of

der eter for å fjerne overskuddet av dime- there ether to remove the excess of dime-

tylanilin. Etter tilsetning av et overskudd av ammoniakk til oppløsningen utvinnes reaksj onsproduktet, N-metylpipekolin-syre-2,6-dimetylanilid, ved ekstraksjon med isoamylalkohol. Isoamylalkoholopp- tylaniline. After adding an excess of ammonia to the solution, the reaction product, N-methylpipecolic acid-2,6-dimethylanilide, is recovered by extraction with isoamyl alcohol. isoamyl alcohol

løsningen inndampes til tørrhet, residuet oppløses i fortynnet saltsyre, behandles med trekull og felles påny med NaOH. the solution is evaporated to dryness, the residue is dissolved in dilute hydrochloric acid, treated with charcoal and combined again with NaOH.

Herved fåes N-metyl-pipekolinsyre-2,6-dimetylanilid i krystallinsk form. This gives N-methyl-pipecolic acid-2,6-dimethylanilide in crystalline form.

Eksempel 2: Example 2:

På en måte tilsvarende den i eksempel In a way similar to the one in the example

1 beskrevne fremstilles det 2-etylanilin-magnesiumbromid av 121 vektsdeler 2- 1 described, 2-ethylaniline-magnesium bromide is prepared from 121 parts by weight 2-

etylanilin, og man lar 2-etylanilinmagne-siumbromidet reagere med 78 deler ni-pekotinsyre-etylester. Etter anvendelse av den i eksempel 1 beskrevne fremgangs- ethylaniline, and the 2-ethylaniline magnesium bromide is allowed to react with 78 parts of ni-pecotic acid ethyl ester. After applying the procedure described in example 1,

måte får man nipekotinsyre-2-etylanilid. method one obtains nipecotic acid-2-ethylanilide.

10 deler av dette anilid oppløses i 16 deler isopropylalkohol og 5,3 deler isopropylbro- 10 parts of this anilide are dissolved in 16 parts of isopropyl alcohol and 5.3 parts of isopropyl bro-

mld, - og det tilsettes 5 deler kaliumkarbo- mld, - and 5 parts of potassium carbo- are added

nat. Blandingen oppvarmes under tilbake- night The mixture is heated under reflux

løpskjøling i 12 timer under omrøring, filt- continuous cooling for 12 hours while stirring, felt-

reres og inndampes til tørrhet. Man opp- stirred and evaporated to dryness. One up-

løser residuet i fortynnet saltsyre og feller påny med alkali, hvorved man får N-iso-propylnipekotinsyre-2-etylanilid i form av den frie base. dissolves the residue in dilute hydrochloric acid and precipitates again with alkali, whereby N-iso-propylnipecotic acid-2-ethylanilide is obtained in the form of the free base.

Eksempel 3: Example 3:

På en måte tilsvarende den i eksem- In a way similar to that in ex-

pel 1 beskrevne fremstilles anilinmagne- pel 1 described are prepared aniline magne-

siumbromid av 93 deler anilin, og man lar sium bromide of 93 parts of aniline, and one lets

aniiinmagnesiumbromidet reagere med 75 the amine magnesium bromide reacts with 75

deler isonikotinsyre-etylester. Den herved dannede magnesiumforbindelse oppløses og hydrolyseres i fortynnet saltsyre, hvorpå oppløsningenes pH-verdi innstilles på om- shares isonicotinic acid ethyl ester. The magnesium compound thus formed is dissolved and hydrolysed in dilute hydrochloric acid, after which the solutions' pH value is adjusted to about

kring 7 og eteren fraskilles. Den tilbake- around 7 and the ether is separated. The back-

blivende vandige oppløsning ekstraheres 2 ganger med isoamylalkohol, og oppløs- remaining aqueous solution is extracted twice with isoamyl alcohol, and dissolve

ningen sammen med eteroppløsningen inndampes til tørrhet. Residuet underkas- The extract together with the ether solution is evaporated to dryness. The residue subject to

tes vanndampdestillasjon inntil det er be- water vapor distillation is carried out until it is be-

fridd fra anilin. Det tilbakeblivende iso-nikotinsyreanilid oppløses i fortynnet salt- freed from aniline. The remaining iso-nicotinic acid anilide is dissolved in dilute salt

syre, behandles med trekull, felles påny med alkali, hvorpå bunnfallet frafiltreres og tørres. 99 deler av isonikotinsyreanili- acid, treated with charcoal, precipitated again with alkali, after which the precipitate is filtered off and dried. 99 parts of isonicotinic acid anili-

det oppløses i 240 deler alkohol og 60 deler iseddik. Oppløsningen tilsettes 2,5 deler platinaoksyd, og anilidet hydreres ved et trykk på 2—5 atmosfærer og en tempera- it dissolves in 240 parts alcohol and 60 parts glacial acetic acid. 2.5 parts of platinum oxide are added to the solution, and the anilide is hydrated at a pressure of 2-5 atmospheres and a temperature

tur på 50—80° C. Når det ikke lenger ab- temperature of 50-80° C. When it no longer ab-

sorberes hydrogen, frafiltreres katalysa- hydrogen is sorbed, the catalysis is filtered off

toren. Filtratet tilsettes 40 deler NaOH tower. 40 parts of NaOH are added to the filtrate

oppløst i vann til en 40—50 pst.'s oppløs- dissolved in water to a 40-50 percent solvent

ning, samt 250 deler eter. Etter nedkjøling frafiltreres det utfelte natriumacetat, og filtratet inndampes til krystallisasjon eller til tørrhet. 10 deler av residuet fra inn-dampningen (eller det krystallinske pro- ning, as well as 250 parts of ether. After cooling, the precipitated sodium acetate is filtered off, and the filtrate is evaporated to crystallization or to dryness. 10 parts of the residue from the evaporation (or the crystalline pro-

dukt) oppløses i 16 deler metanol. Oppløs- duct) is dissolved in 16 parts methanol. dissolve-

ningen tilsettes 5 deler kaliumkarbonat og 5,2 deler dimetylsulfat. Den oppvarmes der- 5 parts of potassium carbonate and 5.2 parts of dimethylsulphate are added to the mixture. It is heated there-

på i 6 timer under tilbakeløpskjøling og omrøring hvorpå oppløsningen filtreres og inndampes til tørrhet. Residuet oppløses i fortynnet saltsyre, behandles med trekull og felles påny med alkali. På denne måte får man krystallinsk N-metylisonipekotin- for 6 hours under reflux and stirring, after which the solution is filtered and evaporated to dryness. The residue is dissolved in dilute hydrochloric acid, treated with charcoal and combined again with alkali. In this way, crystalline N-methylisonipecotin is obtained

syreanilid. acid anilide.

Eksempel 4: Example 4:

På en måte tilsvarende den i eksem- In a way similar to that in ex-

pel 1 beskrevne fremstilles 2-klor-6-metyl-anilin-magnesiumbromid av 141,5 deler 2-klor-6-metylanilin. Man lar derpå sist- pel 1 described, 2-chloro-6-methyl-aniline-magnesium bromide is prepared from 141.5 parts of 2-chloro-6-methylaniline. One then lets last-

nevnte forbindelse reagere med 100 deler N-normalt-butyl-pyrrolidin-a-karbonsyre- said compound react with 100 parts of N-normal-butyl-pyrrolidine-α-carboxylic acid-

ester. Ved å bruke den i eksempel 1 be- ester. Using it in Example 1 be-

skrevne fremgangsmåte får man N-nor-malt-butyl-pyrrolidin-a-karbonsyre-2-klor-6-metylanilid. written procedure gives N-nor-malt-butyl-pyrrolidine-α-carboxylic acid-2-chloro-6-methylanilide.

Claims (5)

1. Fremgangsmåte til fremstilling av anestetisk virkende amider av N-alkylpiperidin-monokarbonsyre og av N-alkylpyrrolidin-a-monokarbonsyre, med de generelle formler:1. Process for the production of anesthetically effective amides of N-alkylpiperidine-monocarboxylic acid and of N-alkylpyrrolidine-α-monocarboxylic acid, with the general formulas: hvor karbonsyreamidgruppén er tilknyttet piperidinringen i alfa-, beta-, eller gamma-stillingen og i hvilke R, betegner en alkylgruppe med mindre enn 10 kull-stoffatomer, R2 en lavere alkylgruppe eller et kloratom, R3 et hydrogenatom, en lavere alkylgruppe eller en alkoksygruppe, R4 betegner et hydrogenatom, et kloratom, en lavere alkylgruppe eller en alkoksygruppe, eller alternativt R2, R3 og R4 alle kan være hydrogen i en og samme forbindelse, karakterisert ved at man lar et anilinmagnesiumhalogenid med den generelle formel: i hvilken X betegner halogen og R2, R3 og R4 har de ovenfor angitte betydninger reagere med en pyridin-monokarbonsyreester eller med en piperidin-monokarbonsyreester eller en pyrrol-a-monokarbonsyreester eller en pyrrolidin-a-monokarbonsyreester, som kan være alkylerte eller ikke alkylerte ved nitrogenatomet i den heterocykliske ring, hvorpå man hydrolyserer det erholdte reaksjonsprodukt med en syre, og i de tilfelle hvor utgangsmaterialet er en pyridinmonokarbonsyreester eller pyr-rol-a-monokarbonsyreester underkaster den heterocykliske ring en fortrinsvis ka-talytisk hydrering med derpå følgende alkylering av nitrogenet i den heterocykliske ring. where the carboxylic acid amide group is linked to the piperidine ring in the alpha, beta, or gamma position and in which R denotes an alkyl group with less than 10 carbon atoms, R2 a lower alkyl group or a chlorine atom, R3 a hydrogen atom, a lower alkyl group or an alkoxy group , R4 denotes a hydrogen atom, a chlorine atom, a lower alkyl group or an alkoxy group, or alternatively R2, R3 and R4 can all be hydrogen in one and the same compound, characterized by allowing an aniline magnesium halide with the general formula: in which X denotes halogen and R 2 , R 3 and R 4 have the above meanings react with a pyridine monocarboxylic acid ester or with a piperidine monocarboxylic acid ester or a pyrrole α-monocarboxylic acid ester or a pyrrolidine α-monocarboxylic acid ester, which may or may not be alkylated alkylated at the nitrogen atom in the heterocyclic ring, whereupon the reaction product obtained is hydrolyzed with an acid, and in cases where the starting material is a pyridine monocarboxylic acid ester or pyrrole-a-monocarboxylic acid ester, the heterocyclic ring undergoes a preferably catalytic hydrogenation with subsequent alkylation of the nitrogen in the heterocyclic ring. 2. Fremgangsmåte ifølge påstand 1, karakterisert ved at man lar 2,6-dimetylanilin-magnesiumbromid reagere med N-metylpipekolinsyre-etylester som hydrolyseres med en syre, hvorved man får N-metylpipekolinsyre-2,6-dimetylanilid. 2. Process according to claim 1, characterized in that 2,6-dimethylaniline-magnesium bromide is allowed to react with N-methylpipecolic acid ethyl ester which is hydrolysed with an acid, thereby obtaining N-methylpipecolic acid-2,6-dimethylanilide. 3. Fremgangsmåte ifølge påstand 1, karakterisert ved at man lar 2-etyl-mag-nesiumbromid reagere med nipekotinsyre-etylester, hydrolyserer reaksjonsproduktet med en syre, hvorved man får nipekotin-syre-2-etylester, og derpå lar denne forbindelse reagere med isopropylbromid hvorved man får N-isopropylnipekotin-syre-2-etylanilid. 3. Process according to claim 1, characterized in that 2-ethyl magnesium bromide is allowed to react with nipecotic acid ethyl ester, the reaction product is hydrolysed with an acid, thereby obtaining nipecotic acid 2-ethyl ester, and then this compound is allowed to react with isopropyl bromide whereby N-isopropylnipecotic acid-2-ethylanilide is obtained. 4. Fremgangsmåte ifølge påstand 1, karakterisert ved at man lar anilinmagne-siumbromid reagere med iso-nikotinsyre-etylester, hydrolyserer reaksjonsproduktet med en syre, hvorved man får isonikotin-syreanilid, hydrerer den heterocykliske ring i dette anilid og derpå lar det hydrerte produkt reagere med dimetylsulfat, hvorved man får N-metylisonipekotin-syreanilid. 4. Process according to claim 1, characterized in that aniline magnesium bromide is allowed to react with isonicotinic acid ethyl ester, the reaction product is hydrolyzed with an acid, whereby isonicotinic acid anilide is obtained, the heterocyclic ring in this anilide is hydrogenated and then the hydrogenated product is allowed to react with dimethyl sulfate, whereby N-methylisonipecotin acid anilide is obtained. 5. Frettngangsmåte ifølge påstand 1, karakterisert ved at man lar 2-klor-6-me-tyl-anilin-magnesiumbromid reagere med N-normalt-butylpyrrolidin-a-karbonsyre-etylester, hydrolyserer reaksjonsproduktet med en syre, hvorved man får N-nor-malt-butyl-pyrrolidin-karbonsyre-2-klor-metylanilid.5. Process according to claim 1, characterized in that 2-chloro-6-methyl-aniline-magnesium bromide is allowed to react with N-normal-butylpyrrolidine-α-carboxylic acid ethyl ester, the reaction product is hydrolyzed with an acid, thereby obtaining N- normal-butyl-pyrrolidine-carbonic acid-2-chloro-methylanilide.
NO163322A 1965-06-09 1966-06-06 NO117866B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6507304A NL6507304A (en) 1965-06-09 1965-06-09

Publications (1)

Publication Number Publication Date
NO117866B true NO117866B (en) 1969-10-06

Family

ID=19793333

Family Applications (1)

Application Number Title Priority Date Filing Date
NO163322A NO117866B (en) 1965-06-09 1966-06-06

Country Status (10)

Country Link
US (1) US3422220A (en)
AT (1) AT259643B (en)
BE (1) BE682209A (en)
CH (1) CH446433A (en)
DE (1) DE1462832A1 (en)
DK (1) DK117724B (en)
ES (1) ES327638A1 (en)
GB (1) GB1146078A (en)
NL (1) NL6507304A (en)
NO (1) NO117866B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175444A (en) * 1967-03-03 1969-12-23 Thorn Aei Radio Valves & Tubes Improvements in Implosion-Resistant Cathode Ray Tubes
US3541251A (en) * 1967-09-19 1970-11-17 Standard Elektrik Lorenz Ag Implosion-protecting frame for television picture tubes and process for its installation
US3614519A (en) * 1967-12-18 1971-10-19 Zenith Radio Corp Cathode-ray tube magnetic shield
JPS597731Y2 (en) * 1979-06-07 1984-03-09 ソニー株式会社 cathode ray tube equipment
JPS5743347A (en) * 1980-08-26 1982-03-11 Mitsubishi Electric Corp Cathode ray tube
GB2105956B (en) * 1981-08-04 1985-02-06 Tokyo Shibaura Electric Co Cathode ray tube device
JPS5851683A (en) * 1981-09-22 1983-03-26 Mitsubishi Electric Corp Cathode-ray tube device
US4551765A (en) * 1981-10-26 1985-11-05 Allied Corporation Cathode ray tube vibration isolator
US4556821A (en) * 1984-03-15 1985-12-03 Rca Corporation Color image display system having an improved external magnetic shield
KR900001701B1 (en) * 1985-03-20 1990-03-19 미쯔비시 뎅기 가부시끼가이샤 Color crt
GB2177539B (en) * 1985-05-20 1989-07-05 Mitsubishi Electric Corp Magnetic shielding system in color television receiver
IT1243083B (en) * 1990-09-28 1994-05-23 Videocolor Spa CATHODE-RAY TUBE EQUIPPED WITH AN ANTI-IMPLOSION BAND

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE627679A (en) * 1962-01-29
NL291096A (en) * 1963-04-03
US3369074A (en) * 1965-04-02 1968-02-13 Warwick Electronics Inc Television tube shield and mounting structure

Also Published As

Publication number Publication date
AT259643B (en) 1968-01-25
US3422220A (en) 1969-01-14
DK117724B (en) 1970-05-25
CH446433A (en) 1967-11-15
GB1146078A (en) 1969-03-19
ES327638A1 (en) 1967-08-16
DE1462832A1 (en) 1968-12-05
BE682209A (en) 1966-12-07
NL6507304A (en) 1966-12-12

Similar Documents

Publication Publication Date Title
NO117866B (en)
US2799679A (en) Process of preparing amides of heterocyclic carboxylic acids
Zaugg et al. 3-Carboxy-2, 5-piperazinedione and Derivatives
NO122789B (en)
PL83235B1 (en)
NO127607B (en)
CA1086740A (en) Piperidinopropyl derivatives and the preparation thereof
NO125911B (en)
NO127606B (en)
JP4966210B2 (en) Improved process for producing nitroguanidine derivatives
SU535907A3 (en) The method of obtaining 1- (4-methyl-6oxy-2-pyrimidinyl) -3-methylpyrazolin-5-one
US2441935A (en) Imidazolidones and method for their manufacture
US2883394A (en) New indole derivatives
US2650232A (en) 2-methyl-3-amino-4,5-di-hydroxymethylpyridine and its salts and the preparation thereof
US2759942A (en) Substituted piperidinecarboxylates and methods of preparing same
US3115499A (en) 1-(2-hydroxyethyl)-3-amino-2-imidazolidine-thione
SU506290A3 (en) The method of obtaining diaminobenzophenone
Janzsó et al. The reactions of flavonoids with p-tosylhydrazine
NO750713L (en)
CN108794559A (en) A method of using hyodesoxycholic acid as Material synthesis lithocholic acid
JPS5811861B2 (en) piperidine
NO117867B (en)
US2648666A (en) Quaternary ammonium salts derived
US2724710A (en) 4-pyridazinecarboxylic acid and salts thereof with bases
US2681340A (en) Amino esters